13F Pro13F Pro

Verdad Advisers, LP

Institutional InvestorSimilar funds →SEC EDGAR: CIK 1812822
Institutional-grade research for retail investors

Sector Allocation

  • Healthcare50.0%$52.2M
  • Technology19.1%$19.9M
  • Financials9.3%$9.7M
  • Communication Services5.1%$5.3M
  • Consumer Discretionary4.6%$4.8M
  • Real Estate3.5%$3.7M
  • Materials2.6%$2.7M
  • Industrials2.5%$2.6M
  • Energy2.1%$2.2M
  • Consumer Staples1.3%$1.4M

AUM History

13fpro.ai/research/fund/verdad-advisers-lp-1812822

Largest positions — Q2 2026

Top 20 stock positions. Options are left out: 13F reports them at the underlying's value.

13fpro.ai/research/fund/verdad-advisers-lp-1812822

Verdad Advisers, LP 13F holdings — Q2 2026

$104.4M portfolio (+17.5% QoQ) · 210 holdings · Q2 2026 13F · top 10 are 18% of the stock portfolio

All holdings — Verdad Advisers, LP (Q2 2026)

210 disclosed positions from the Form 13F-HR on SEC EDGAR, with quarter-over-quarter share changes. Largest by value first; the ten above are not repeated.

Company
VSNT$VSNTVersant Media Group, Inc.$1.6M+129%
NTCT$NTCTNETSCOUT SYSTEMS INC$1.4M+125%
WHWK$WHWKWhitehawk Therapeutics, Inc.$1.4M+161%
JNJ$JNJJOHNSON & JOHNSON$1.4M-0.6%
CTNM$CTNMContineum Therapeutics, Inc.$1.3M-6%
JBIO$JBIOJade Biosciences, Inc.$1.3MNew
CSCO$CSCOCISCO SYSTEMS, INC.$1.2MNew
NRIX$NRIXNurix Therapeutics, Inc.$1.2M-41%
TARA$TARAProtara Therapeutics, Inc.$1.2MNew
BLMN$BLMNBloomin' Brands, Inc.$1.2M+30%
TYRA$TYRATyra Biosciences, Inc.$1.1MNew
PARR$PARRPAR PACIFIC HOLDINGS, INC.$1.1M-11%
EWTX$EWTXEdgewise Therapeutics, Inc.$1.1M+109%
GOOGL$GOOGLAlphabet Inc.$1.0MNew
CRI$CRICARTERS INC$1.0M—

What changed in Q2 2026

Against the previous quarter's 13F: 97 new, 59 added to, 42 trimmed, 66 sold out. Share-count changes; largest moves by dollar size first.

New positions (97)

  • AAPL$AAPLApple Inc.$2.2M

    first bought this quarter

  • XFOR$XFORX4 Pharmaceuticals, Inc$1.6M

    first bought this quarter

  • JBIO$JBIOJade Biosciences, Inc.$1.3M

    first bought this quarter

  • CSCO$CSCOCISCO SYSTEMS, INC.$1.2M

    first bought this quarter

  • TARA$TARAProtara Therapeutics, Inc.$1.2M

    first bought this quarter

  • TYRA$TYRATyra Biosciences, Inc.$1.1M

    first bought this quarter

+91 more in the Excel export

Added to (59)

  • SLDE$SLDESlide Insurance Holdings, Inc.+197%

    now $1.8M · held 2 qtrs, 2 adds in a row

  • CCZ$CCZCOMCAST CORP+104%

    now $2.1M · held 3+ qtrs

  • VSNT$VSNTVersant Media Group, Inc.+129%

    now $1.6M · held 2 qtrs, 2 adds in a row

  • WHWK$WHWKWhitehawk Therapeutics, Inc.+161%

    now $1.4M · held 2 qtrs, 2 adds in a row

  • NTCT$NTCTNETSCOUT SYSTEMS INC+125%

    now $1.4M · held 2 qtrs, 2 adds in a row

  • EWTX$EWTXEdgewise Therapeutics, Inc.+109%

    now $1.1M · held 2 qtrs, 2 adds in a row

+53 more in the Excel export

Trimmed (42)

  • MU$MUMICRON TECHNOLOGY INC-89%

    now $484K · held 3+ qtrs, 2 trims in a row

  • RVMD$RVMDRevolution Medicines, Inc.-81%

    now $759K · held 2 qtrs

  • LRCX$LRCXLAM RESEARCH CORP-83%

    now $387K · held 3+ qtrs, 2 trims in a row

  • AMAT$AMATAPPLIED MATERIALS INC /DE-62%

    now $787K · held 2 qtrs

  • CLYM$CLYMClimb Bio, Inc.-68%

    now $601K · held 2 qtrs

  • ZM$ZMZoom Communications, Inc.-67%

    now $615K · held 3+ qtrs

+36 more in the Excel export

Sold out (66)

  • STT$STTSTATE STREET CORPwas $2.1M

    held 1 qtr

  • ATHM$ATHMAutohome Inc.was $2.1M

    held 1 qtr

  • CALM$CALMCAL-MAINE FOODS INCwas $2.0M

    held 2+ qtrs

  • AXSM$AXSMAxsome Therapeutics, Inc.was $1.0M

    held 1 qtr

  • CVX$CVXCHEVRON CORPwas $936K

    held 2+ qtrs

  • NGL$NGLNGL Energy Partners LPwas $863K

+60 more in the Excel export

Firm AUM (Form ADV): $1.2B as of 2025-12-31 · SEC IAPD

Share

Holdings by quarter

Every 13F Verdad Advisers, LP has filed, 19 earlier quarters. Pick one to see what it held then.

Email me the moment this fund files its next 13FPro

Is it too late to follow Verdad Advisers?

Q2 2026 13F filed with the SEC on Aug 14, 2026. Prices are closing prices as of Oct 26, 2026.

Average quality of Verdad Advisers's top 20 holdings: 53/100 (our AI quality score, weighted by position size; 15 of the 20 are scored)

Top 10 since filing

+2.8%

Value-weighted move of the 10 largest stock positions

Turnover

53%

Last quarter

Top 10 weight

18%

Share of the stock portfolio in its 10 largest positions

Held 4+ quarters

0%

Share of portfolio value in positions held a year or more

Highest-quality names it owns(among its 100 largest positions)

The 8 highest-scoring companies in this portfolio are a Pro feature.

How these are measured
  • Moves since the quarter-end and since the filing date use our own daily closing prices, from the close on (or just before) each date to the latest close.
  • Turnover is the lesser of shares bought or sold in a quarter, valued at the quarter-end prices in the 13F, divided by the average of the two quarters' stock portfolio values.
  • Quarters held and add/trim streaks count back only through quarters whose filed holdings add up to the filing's own cover-page total (back to Q4 2025 for this fund). A change counts as an add or a trim when the split-adjusted share count moves by more than 1%.
  • Estimate, not the fund's reported cost. For each quarter in the current holding period in which the fund's share count rose (split-adjusted), we take that quarter's average daily close and weight it by the shares added; sales do not change an average cost. Quarters where the stock's price history and the 13F's own implied price disagree by more than 2x are left out.
  • Put and call option rows report the value of the underlying shares, not a position the fund paid for, so they are left out of all of the above.

Portfolio Overview

Verdad Advisers, LP disclosed 210 positions worth $104.4M in its Form 13F-HR for Q2 2026, led by $AAPL (Apple Inc.) at 2.1% of the equity portfolio, followed by $BLTE and $ACAD. During the quarter the fund opened 97 new positions and exited 66 — including a new stake in $AAPL and a full exit from $STT. The portfolio is most concentrated in Healthcare (50.0% of disclosed assets). All figures are sourced directly from Verdad Advisers, LP’s Form 13F-HR filing with the SEC under CIK 1812822.

Funds like this

managers whose biggest positions overlap Verdad Advisers's
Paradigm Biocapital Advisors LP$5.34B 13F book · 5 shared top holdingsBLTEJBIOTYRAEWTXPERCEPTIVE ADVISORS LLC$6.66B 13F book · 5 shared top holdingsZYMENRIXEWTXNUVLRA CAPITAL MANAGEMENT, L.P.$11.51B 13F book · 5 shared top holdingsTYRAEWTXNUVLJBIOAffinity Asset Advisors, LLC$2.21B 13F book · 6 shared top holdingsBLTENRIXNUVLDNTHBAKER BROS. ADVISORS LP$19.96B 13F book · 5 shared top holdingsACADEWTXNRIXDNTHLogos Global Management LP$2.32B 13F book · 5 shared top holdingsBLTEJBIOVERADNTH

Browse Top Institutional Investors

13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.

Berkshire HathawayBridgewater AssociatesCitadel AdvisorsRenaissance TechnologiesTwo Sigma InvestmentsDE Shaw & CoMillennium ManagementAQR Capital ManagementPoint72 Asset ManagementTiger Global ManagementVanguard GroupBlackRock

to search all 8,700+ institutional filers.

AI-Powered Hedge Fund Analysis: Verdad Advisers, LP

13F Pro is an AI hedge fund tracker and stock research platform. For Verdad Advisers, LP (SEC CIK: 1812822), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.

Every holding in Verdad Advisers, LP's portfolio is scored on an AI quality ranking built from its SEC filings (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.